SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-16-004966
Filing Date
2016-01-21
Accepted
2016-01-21 17:10:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 AVALANCHE BIOTECHNOLOGIES, INC. p16-0135sc13g.htm SC 13G 67353
  Complete submission text file 0000902664-16-004966.txt   68778
Mailing Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025 650-272-6269
Avalanche Biotechnologies, Inc. (Subject) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88266 | Film No.: 161354122
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address RIVERBANK HOUSE, 2 SWAN LANE LONDON X0 EC4R 3AD
Business Address RIVERBANK HOUSE, 2 SWAN LANE LONDON X0 EC4R 3AD 44 202 7144 1000
Man Group plc (Filed by) CIK: 0001637460 (see all company filings)

IRS No.: 000000000
Type: SC 13G